163 related articles for article (PubMed ID: 29467385)
1. The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling.
Yang Y; Liu Y; Guo R; Fu Y; Zhang Z; Zhang P; Zhou P; Wang T; Huang T; Li X; Li C
Sci Rep; 2018 Feb; 8(1):3398. PubMed ID: 29467385
[TBL] [Abstract][Full Text] [Related]
2. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.
Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJ; Richardson DR
J Biol Chem; 2016 Jan; 291(3):1029-52. PubMed ID: 26534963
[TBL] [Abstract][Full Text] [Related]
3. SV40 T/t-common polypeptide inhibits angiogenesis and growth of HER2-overexpressing human ovarian cancer.
Hsueh SP; Hsu WB; Wen CC; Wang WB
Cancer Gene Ther; 2011 Dec; 18(12):859-70. PubMed ID: 21869825
[TBL] [Abstract][Full Text] [Related]
4. Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers.
Baldassarre T; Truesdell P; Craig AW
Breast Cancer Res; 2017 Oct; 19(1):110. PubMed ID: 28974266
[TBL] [Abstract][Full Text] [Related]
5. Caffeic acid phenethyl ester upregulates N-myc downstream regulated gene 1 via ERK pathway to inhibit human oral cancer cell growth in vitro and in vivo.
Chung LC; Chiang KC; Feng TH; Chang KS; Chuang ST; Chen YJ; Tsui KH; Lee JC; Juang HH
Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28181403
[TBL] [Abstract][Full Text] [Related]
6. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway.
Du C; Yi X; Liu W; Han T; Liu Z; Ding Z; Zheng Z; Piao Y; Yuan J; Han Y; Xie M; Xie X
BMC Cancer; 2014 Nov; 14():869. PubMed ID: 25417825
[TBL] [Abstract][Full Text] [Related]
7. Mollugin inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells.
Do MT; Hwang YP; Kim HG; Na M; Jeong HG
J Cell Physiol; 2013 May; 228(5):1087-97. PubMed ID: 23065756
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
[TBL] [Abstract][Full Text] [Related]
9. The vicious cycle between ferritinophagy and ROS production triggered EMT inhibition of gastric cancer cells was through p53/AKT/mTor pathway.
Xu Z; Feng J; Li Y; Guan D; Chen H; Zhai X; Zhang L; Li C; Li C
Chem Biol Interact; 2020 Sep; 328():109196. PubMed ID: 32687844
[TBL] [Abstract][Full Text] [Related]
10. The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways.
Guerram M; Jiang ZZ; Yousef BA; Hamdi AM; Hassan HM; Yuan ZQ; Luo HW; Zhu X; Zhang LY
Oncotarget; 2015 Sep; 6(26):21865-77. PubMed ID: 26068969
[TBL] [Abstract][Full Text] [Related]
11. Degradation of HER2 by Cbl-based chimeric ubiquitin ligases.
Li X; Shen L; Zhang J; Su J; Shen L; Liu X; Han H; Han W; Yao L
Cancer Res; 2007 Sep; 67(18):8716-24. PubMed ID: 17875712
[TBL] [Abstract][Full Text] [Related]
12. A novel antitumor dithiocarbamate compound inhibits the EGFR/AKT signaling pathway and induces apoptosis in esophageal cancer cells.
Yang Y; Tian Z; Zhao X; Li Y; Duan S
Oncol Lett; 2020 Jul; 20(1):877-883. PubMed ID: 32566015
[TBL] [Abstract][Full Text] [Related]
13. N-myc downstream regulated gene 1 acts as a tumor suppressor in ovarian cancer.
Wang B; Li J; Ye Z; Li Z; Wu X
Oncol Rep; 2014 May; 31(5):2279-85. PubMed ID: 24626771
[TBL] [Abstract][Full Text] [Related]
14. BMP9 inhibits proliferation and metastasis of HER2-positive SK-BR-3 breast cancer cells through ERK1/2 and PI3K/AKT pathways.
Ren W; Liu Y; Wan S; Fei C; Wang W; Chen Y; Zhang Z; Wang T; Wang J; Zhou L; Weng Y; He T; Zhang Y
PLoS One; 2014; 9(5):e96816. PubMed ID: 24805814
[TBL] [Abstract][Full Text] [Related]
15. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways.
Ma W; Na M; Tang C; Wang H; Lin Z
Mol Med Rep; 2015 Jul; 12(1):1050-8. PubMed ID: 25777142
[TBL] [Abstract][Full Text] [Related]
17. N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase.
Akiba J; Murakami Y; Noda M; Watari K; Ogasawara S; Yoshida T; Kawahara A; Sanada S; Yasumoto M; Yamaguchi R; Kage M; Kuwano M; Ono M; Yano H
Cancer Lett; 2011 Nov; 310(1):25-34. PubMed ID: 21775055
[TBL] [Abstract][Full Text] [Related]
18. Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells.
Song YH; Jeong SJ; Kwon HY; Kim B; Kim SH; Yoo DY
Biol Pharm Bull; 2012; 35(7):1022-8. PubMed ID: 22791147
[TBL] [Abstract][Full Text] [Related]
19. Houttuyninum, an active constituent of Chinese herbal medicine, inhibits phosphorylation of HER2/neu receptor tyrosine kinase and the tumor growth of HER2/neu-overexpressing cancer cells.
Zhou NN; Tang J; Chen WD; Feng GK; Xie BF; Liu ZC; Yang D; Zhu XF
Life Sci; 2012 May; 90(19-20):770-5. PubMed ID: 22525372
[TBL] [Abstract][Full Text] [Related]
20. Stable suppression of HER-2 gene expression using siRNA increases the lysis of human ovarian carcinoma cells mediated by NK-92 cell line.
Zhou Y; Cheng Z; Zhu H; Feng D; Zhao W; Ling B; Wei H; Tian Z
Oncol Rep; 2008 Dec; 20(6):1425-31. PubMed ID: 19020724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
